Generate Biomedicines Shares Begin Trading Below IPO Price in Nasdaq Debut
Generate Biomedicines, Inc. (NASDAQ:GENB) began trading on the Nasdaq Global Select Market at $15 per share, under its initial public offering price of $16. The company sold 25,000,000 common shares in the offering, aiming to raise $400 million in gross proceeds before underwriting discounts and commissions. Generate is advancing a late-stage asthm…